What are dopamine agonists?

Dopamine agonists are a class of medications used to mimic the effects of dopamine, a neurotransmitter that plays a crucial role in movement and coordination. In Parkinson’s, dopamine-producing neurons in the brain progressively deteriorate. This leads to motor symptoms such as tremor, stiffness, and slowed movement. Dopamine agonists stimulate dopamine receptors, helping to alleviate these symptoms without directly replacing dopamine like levodopa-based treatments.

Dopamine agonists are often prescribed in the early stages of Parkinson’s or alongside levodopa to enhance symptom control and are an important pharmacotherapeutic agent. They can help:

  • Reduce motor fluctuations, particularly “off” periods when symptoms return between doses of levodopa.
  • Delay the need for levodopa, potentially postponing the onset of levodopa-induced dyskinesia (involuntary movements).
  • Provide longer-lasting symptom relief, as dopamine agonists remain active in the body for extended periods.
  • Dopamine agonists, such as ropinirole, are the first-line treatment for restless legs syndrome.

How are dopamine agonists used?

Dopamine agonists are available in various forms, including:

  • Tablets (e.g., pramipexole, ropinirole) taken orally. There are two tablet forms: immediate or extended-release tablets.
  • Skin patches (e.g., rotigotine) for continuous absorption.
  • Injectable formulations (e.g., apomorphine) for rapid symptom relief. Apomorphine is administered by subcutaneous injection.

Treatment typically starts with a low dose, gradually increasing to minimise side effects. Some patients may use dopamine agonists alone, while others combine them with levodopa therapy for enhanced symptom management.

 Benefits of dopamine agonists

  • Mimic dopamine activity, improving motor symptoms.
  • Longer duration of action compared to levodopa, reducing fluctuations.
  • Lower risk of dyskinesia when used early in treatment.
  • Available in multiple formulations, offering flexibility in treatment.

 Risks and side effects

Nausea, vomiting, orthostatic hypotension, headache, dizziness, and cardiac arrhythmia are the most common side effect of dopamine agonists. These adverse effects are mostly dosage-dependent. It is highly recommended to start these medications at a low dosage to reduce the risk of orthostatic hypotension. Serotonin receptor antagonist antiemetics should not be taken together as they may enhance the hypotensive effect of dopamine agonists. While effective, dopamine agonists can also cause the above side effects, including:

  • Nausea and vomiting, especially when starting treatment.
  • Low blood pressure, leading to dizziness or fainting.
  • Irresistible sleep attacks may occur in patients who are taking pramipexole and ropinirole. Symptoms such as increased sedation, yawning, drowsiness, somnolence, and daytime sleepiness have been observed with dopamine agonist use.
  • Hallucinations or confusion, particularly in older patients.
  • Impulse control disorders, such as compulsive gambling, shopping, or eating.

 Considerations before use 

Dopamine agonist use requires caution in patients with a medical history of hypertension, cardiovascular, renal, and hepatic disease. Dopamine agonists may not be suitable for people with:

  • Severe cognitive impairment, as they can worsen confusion.
  • Psychiatric conditions, due to potential mood changes.
  • Some formulations may affect blood pressure.
  • Contraindications to dopamine agonists include pregnancy and for nursing mothers, as these medications inhibit lactation.

References 

Choi J, Horner KA. Dopamine Agonists. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551686/

Parkinson’s Foundation. (2025). Dopamine agonists: Mechanisms and treatment considerations. Retrieved from https://www.parkinson.org/living-with-parkinsons/treatment/prescription-medications/dopamine-antagonists

Parkinson’s UK. (2025). Dopamine agonists: Uses, benefits, and side effects. Retrieved from https://www.parkinsons.org.uk/information-and-support/dopamine-agonists-pramipexole-ropinirole

Healthline. (2025). Dopamine agonists: Common uses, side effects, and more. Retrieved from https://www.healthline.com/health/parkinsons-disease/dopamine-agonist

Share

Other articles

  • Employment | Disability Support Pension

    The DSP is an Australian Government income support payment for people who are under Age Pension age and whose medical condition significantly limits their ability to work. It is administered by Services Australia (Centrelink). The DSP is not based on your diagnosis alone. It is based on how your condition affects your daily functioning and your capacity to work — now and over the next two years. You may be eligible if you are under 65, have Parkinson's and meet both non-medical and medical criteria.

  • Gut, Bladder, Bowel | Managing bladder issues

    Living with Parkinson’s bladder issues can add an extra layer of frustration. With the right support and strategies, you can manage and even alleviate bladder issues to improve your quality of life.

  • CARERS | Carer Gateway support packages

    Parkinson’s is a progressive condition, so caring needs tend to grow over time. Getting support in place early, before you reach burnout,  is one of the most practical things you can do for yourself and for the person you care for. A lot of carers hold off because they feel their situation is not "bad enough," or that others have it harder. Carer Gateway is not just for crisis. If you are an unpaid carer for someone with Parkinson’s, you are eligible, full stop. Free support is available for Parkinson's care partners through Carer Gateway. Read more to find out what you can access and how to get started today.